Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT03658005
Eligibility Criteria:
Inclusion Criteria:
* Patients aged over 18 years and less than 90 years,
* Patients admitted for myocardial infarction treated with ticagrelor in association with aspirin.
* Patients affiliated to a social security system (or be a beneficiary thereof);
* Sign written informed consent indicating that they have understood the study procedures and objectives, and that they accept to participate and adhere to the study requirements.
Exclusion Criteria:
* Patients with limited legal capacity or patients under legal guardianship
* Patients under judicial protection
* Patients not affiliated to any social security system
* Patients taking any antiplatelet agent other than ticagrelor Patients taking ticagrelor for \<48 hours (treatment not stabilised) Patients with hemoglobin concentration \<10 g/dL on the most recent blood test
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT03658005
Study Brief:
Protocol Section:
NCT03658005